Recent Advances in Gene Therapy-Based Cancer Monotherapy and Synergistic Bimodal Therapy Using Upconversion Nanoparticles: Structural and Biological Aspects

Recent Advances in Gene Therapy-Based Cancer Monotherapy and Synergistic Bimodal Therapy Using Upconversion Nanoparticles: Structural and Biological Aspects Publisher Pubmed

Sohrabi M¹ ; Babaei Z¹ ; Haghpanah V¹ ; Larijani B¹ ; Abbasi A¹ ; Mahdavi M¹

Show Affiliations

1. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Biomedicine and Pharmacotherapy Published:2022

Abstract

In accordance with human genetics and genomics advances over the past years, it can be found that cancer is created through a somatic aberration in the host genome. Accordingly, researchers use therapeutic methods in genetic manipulation to discover the possible cure for the disease. In combination with traditional cancer treatments, gene therapy (GT) is essential in future cancer therapy. The development of powerful nanocarriers for targeted, controlled, and efficient intracellular delivery of therapeutic biomolecules that increase pharmacokinetics indicates that the development of GT is highly dependent on nanotechnology. Among nanocarriers, upconversion nanoparticles (UCNPs) have become the focus of great attention in the realm of inorganic nanomedicines following the strategy of “diagnosis for treatment” due to their outstanding features including safety, deep penetration of near-infrared (NIR) light into tissue, and reduction of unfavorable side effects of NIR-triggered therapies. Moreover, various individual therapies can be intelligently combined into a single nanotranostic system based on a UCNP platform for multimodal synergistic treatment. Given that the preparation of multifunctional nanomaterials is a prerequisite for the realization of cancer treatment, especially synergistic therapies, the recognition of the main components of advanced nanoparticles can help researchers in choosing the proper platform for cancer treatment. In view of this, the main goal of this review is to highlight the latest advances in the construction and application of upconversion nanoparticles as carriers for gene delivery and gene editing in cancer monotherapy and bimodal synergistic therapy, with an emphasis on the structural and biological aspects of these studies. © 2022

Related Docs

View other Related Docs

1. Nano-Scale Delivery Systems for Sirna Delivery in Cancer Therapy: New Era of Gene Therapy Empowered by Nanotechnology, Environmental Research (2023)

2. Smart Arginine-Equipped Polycationic Nanoparticles for P/Crispr Delivery Into Cells, Nanotechnology (2022)

3. In Vivo Gene Delivery Mediated by Non-Viral Vectors for Cancer Therapy, Journal of Controlled Release (2020)

4. Layer by Layer Assembled Chitosan-Coated Gold Nanoparticles for Enhanced Sirna Delivery and Silencing, International Journal of Molecular Sciences (2021)

5. Smart Strategies for Precise Delivery of Crispr/Cas9 in Genome Editing, ACS Applied Bio Materials (2022)

6. Glyco-Nanoparticles: New Drug Delivery Systems in Cancer Therapy, Seminars in Cancer Biology (2021)

7. A Concise Review on Cancer Treatment Methods and Delivery Systems, Journal of Drug Delivery Science and Technology (2019)

8. Smart External Stimulus-Responsive Nanocarriers for Drug and Gene Delivery, Smart External Stimulus-Responsive Nanocarriers for Drug and Gene Delivery (2015)

Experts (# of related papers)

View all Related Experts

Ziba Veisi Malekshahi (2)

Fatameh Mottaghitalab (2)

Style	Citing Format
MLA	Sohrabi M, et al.. "Recent Advances in Gene Therapy-Based Cancer Monotherapy and Synergistic Bimodal Therapy Using Upconversion Nanoparticles: Structural and Biological Aspects." Biomedicine and Pharmacotherapy, vol. 156, no. , 2022, pp. -.
APA	Sohrabi M, Babaei Z, Haghpanah V, Larijani B, Abbasi A, Mahdavi M (2022). Recent Advances in Gene Therapy-Based Cancer Monotherapy and Synergistic Bimodal Therapy Using Upconversion Nanoparticles: Structural and Biological Aspects. Biomedicine and Pharmacotherapy, 156(), -.
Chicago	Sohrabi M, Babaei Z, Haghpanah V, Larijani B, Abbasi A, Mahdavi M. "Recent Advances in Gene Therapy-Based Cancer Monotherapy and Synergistic Bimodal Therapy Using Upconversion Nanoparticles: Structural and Biological Aspects." Biomedicine and Pharmacotherapy 156, no. (2022): -.
Harvard	Sohrabi M et al. (2022) 'Recent Advances in Gene Therapy-Based Cancer Monotherapy and Synergistic Bimodal Therapy Using Upconversion Nanoparticles: Structural and Biological Aspects', Biomedicine and Pharmacotherapy, 156(), pp. -.
Vancouver	Sohrabi M, Babaei Z, Haghpanah V, Larijani B, Abbasi A, Mahdavi M. Recent Advances in Gene Therapy-Based Cancer Monotherapy and Synergistic Bimodal Therapy Using Upconversion Nanoparticles: Structural and Biological Aspects. Biomedicine and Pharmacotherapy. 2022;156():-.
BibTex	@article{ author = {Sohrabi M and Babaei Z and Haghpanah V and Larijani B and Abbasi A and Mahdavi M}, title = {Recent Advances in Gene Therapy-Based Cancer Monotherapy and Synergistic Bimodal Therapy Using Upconversion Nanoparticles: Structural and Biological Aspects}, journal = {Biomedicine and Pharmacotherapy}, volume = {156}, number = {}, pages = {-}, year = {2022} }
RIS	TY - JOUR AU - Sohrabi M AU - Babaei Z AU - Haghpanah V AU - Larijani B AU - Abbasi A AU - Mahdavi M TI - Recent Advances in Gene Therapy-Based Cancer Monotherapy and Synergistic Bimodal Therapy Using Upconversion Nanoparticles: Structural and Biological Aspects JO - Biomedicine and Pharmacotherapy VL - 156 IS - SP - EP - PY - 2022 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract